Phibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $193 million versus the consensus estimate of $189.9 million.

Highlights for the September 2017 quarter (compared to the September 2016 quarter)

• Net sales of $193 million, an increase of $5 million, or 3%
• Net income of $16 million, an increase of $4 million, or 31%
• Diluted EPS of $0.39, an increase of $0.08, or 26%
• Adjusted EBITDA of $30 million, an increase of less than $1 million, or 1%
• Adjusted diluted EPS of $0.38, an increase of $0.02, or 6%

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.